These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 171663)
1. Comparison between growth characteristics of an Epstein--Barr virus (EBV)-genome-negative lymphoma line and its EBV-converted subline in vitro. Steinitz M; Klein G Proc Natl Acad Sci U S A; 1975 Sep; 72(9):3518-20. PubMed ID: 171663 [TBL] [Abstract][Full Text] [Related]
4. Cell-density-dependence for growth in agarose of two human lymphoma lines and its decrease after Epstein-Barr virus conversion. Montagnier L; Gruest J Int J Cancer; 1979 Jan; 23(1):71-5. PubMed ID: 215564 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-induced increase in the concanavalin-A receptor density of established EBV-negative lymphoma lines in vitro. Siegert W; Mönch T; Valet G Exp Hematol; 1980 Nov; 8(10):1173-82. PubMed ID: 6262102 [TBL] [Abstract][Full Text] [Related]
6. Possible DNA-RNA tumor virus interaction in human lymphomas: expression of retroviral proteins in Ramos lymphoma lines is enhanced after conversion with Epstein-Barr virus. Lasky RD; Troy FA Proc Natl Acad Sci U S A; 1984 Jan; 81(1):33-7. PubMed ID: 6320170 [TBL] [Abstract][Full Text] [Related]
7. Changes in the protein composition of Epstein-Barr Virus-negative lymphoma cells after EBV-conversion. Siegert W; Mönch T Anticancer Res; 1983; 3(1):11-6. PubMed ID: 6299173 [TBL] [Abstract][Full Text] [Related]
8. Post-transcriptional mechanisms of deregulation of MYC following conversion of a human B cell line by Epstein-Barr virus. Lacy J; Summers WP; Summers WC EMBO J; 1989 Jul; 8(7):1973-80. PubMed ID: 2551670 [TBL] [Abstract][Full Text] [Related]
9. Interactions between Epstein-Barr virus (EBV) and human cell lines: growth and EBV induction. Takimoto T; Iwawaki J; Tanaka S; Umeda R ORL J Otorhinolaryngol Relat Spec; 1990; 52(1):40-6. PubMed ID: 2154734 [TBL] [Abstract][Full Text] [Related]
10. Conversion of the lymphoma line "BJAB" by Epstein-Barr virus into phenotypically altered sublines is accompanied by increased c-myc mRNA levels. Wennborg A; Aman P; Saranath D; Pear W; Sümegi J; Klein G Int J Cancer; 1987 Aug; 40(2):202-6. PubMed ID: 3038758 [TBL] [Abstract][Full Text] [Related]
11. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus. Fresen KO; zur Hausen H Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313 [TBL] [Abstract][Full Text] [Related]
12. Amplification and deregulation of MYC following Epstein-Barr virus infection of a human B-cell line. Lacy J; Summers WP; Watson M; Glazer PM; Summers WC Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5838-42. PubMed ID: 3039510 [TBL] [Abstract][Full Text] [Related]
13. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures. Cuomo L; Trivedi P; Wang F; Winberg G; Klein G; Masucci MG Eur J Immunol; 1990 Oct; 20(10):2293-9. PubMed ID: 2173662 [TBL] [Abstract][Full Text] [Related]
14. Cell surface glycoprotein patterns of two EBV-negative lines and their EBV converted sublines. Koide N; Wells A; Klein G; Ernberg I Intervirology; 1981; 16(3):142-8. PubMed ID: 6277822 [TBL] [Abstract][Full Text] [Related]
15. Differential cytotoxicity of tumour promoter TPA for EBV-negative human lymphoma cell lines and their EBV-converted sublines. Béchet JM; Guétard D Int J Cancer; 1983 Jul; 32(1):61-5. PubMed ID: 6305854 [TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus (EBV) and human hematopoietic cell lines: a review. Tatsumi E Hum Cell; 1992 Mar; 5(1):79-86. PubMed ID: 1329932 [TBL] [Abstract][Full Text] [Related]
17. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Klein G; Giovanella B; Westman A; Stehlin JS; Mumford D Intervirology; 1975; 5(6):319-34. PubMed ID: 181343 [TBL] [Abstract][Full Text] [Related]
18. Retrovirus-like particles in EBV-negative Burkitt's lymphoma cell line but not in EBV-DNA-positive lines from patients with ataxia telangiectasia and Down's syndrome. Kotler M; Balabanova H; Friedmann A; Becker Y Br J Cancer; 1979 Apr; 39(4):414-21. PubMed ID: 220999 [TBL] [Abstract][Full Text] [Related]
19. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines. Dillner J; Kallin B; Alexander H; Ernberg I; Uno M; Ono Y; Klein G; Lerner RA Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6641-5. PubMed ID: 3018741 [TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma. Menezes J; Leibold W; Klein G; Clements G Biomedicine; 1975 Jul; 22(4):276-84. PubMed ID: 179629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]